COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.

Australia / epidemiology COVID-19 COVID-19 Vaccines Consensus Hematology Humans New Zealand / epidemiology Prospective Studies SARS-CoV-2 Vaccination
COVID-19 haematology leukaemia lymphoma plasma cell vaccination

Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
05 2021
Historique:
received: 01 02 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 3 6 2021
Statut: ppublish

Résumé

Australia and New Zealand have achieved excellent community control of COVID-19 infection. In light of the imminent COVID-19 vaccination roll out in both countries, representatives from the Haematology Society of Australia and New Zealand and infectious diseases specialists have collaborated on this consensus position statement regarding COVID-19 vaccination in patients with haematological disorders. It is our recommendation that patients with haematological malignancies, and some benign haematological disorders, should have expedited access to high-efficacy COVID-19 vaccines, given that these patients are at high risk of morbidity and mortality from COVID-19 infection. Vaccination should not replace other public health measures in these patients, given that the effectiveness of COVID-19 vaccination, specifically in patients with haematological malignancies, is not known. Given the limited available data, prospective collection of safety and efficacy data of COVID-19 vaccination in this patient group is a priority.

Identifiants

DOI: 10.1111/imj.15247 PMID: 34047035 PMC: PMC8206846
pubmed: 34047035
doi: 10.1111/imj.15247
pmc: PMC8206846
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

763-768

Informations de copyright

© 2021 Royal Australasian College of Physicians.

Références

Leukemia. 2021 Feb;35(2):485-493
pubmed: 33414483
Leukemia. 2020 Sep;34(9):2533-2535
pubmed: 32641732
Am J Hematol. 2004 Oct;77(2):204
pubmed: 15389916
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Cancer Cell. 2021 Feb 8;39(2):257-275.e6
pubmed: 33476581
Blood Cancer J. 2020 Oct 19;10(10):103
pubmed: 33077708
Acta Biomed. 2020 Sep 07;91(3):e2020007
pubmed: 32921705
Blood. 2006 Oct 15;108(8):2509-19
pubmed: 16778145
Blood. 2020 Dec 17;136(25):2881-2892
pubmed: 33113551
Blood. 2015 Jul 23;126(4):454-62
pubmed: 26065657
Blood. 2020 Aug 20;136(8):925-935
pubmed: 32582924
Hematol Oncol Clin North Am. 2018 Aug;32(4):581-594
pubmed: 30047412
Blood. 2020 Sep 3;136(10):1134-1143
pubmed: 32688395
Leukemia. 2021 Jan;35(1):31-44
pubmed: 32814840
Blood Adv. 2020 Apr 14;4(7):1378-1382
pubmed: 32267929
Br J Haematol. 2007 Sep;138(5):563-79
pubmed: 17686051
Lancet Public Health. 2020 Nov;5(11):e569-e570
pubmed: 33065024
Haematologica. 2015 Jan;100(1):107-13
pubmed: 25344526
Cell. 2020 Dec 23;183(7):1901-1912.e9
pubmed: 33248470
J Oncol Pharm Pract. 2020 Oct;26(7):1676-1682
pubmed: 32854573
Hematology Am Soc Hematol Educ Program. 2008;:212-8
pubmed: 19074085
Anesth Analg. 2018 Mar;126(3):928-944
pubmed: 29099429
Intern Med J. 2020 Jun;50(6):667-679
pubmed: 32415723
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Clin Infect Dis. 2014 Feb;58(3):e44-100
pubmed: 24311479
Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):495-502
pubmed: 27364264
Blood. 2015 Jul 30;126(5):573-81
pubmed: 26084672
Leukemia. 2020 Sep;34(9):2354-2363
pubmed: 32647324
Am J Hematol. 2020 Aug;95(8):E198-E199
pubmed: 32311145
Blood. 2020 Dec 24;136(26):3033-3040
pubmed: 33367546
Arch Dis Child. 2001 Mar;84(3):227-9
pubmed: 11207170
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246

Auteurs

Georgia McCaughan (G)

Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
St Vincent's Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
ORCID: 0000-0002-4838-9022

Pietro Di Ciaccio (P)

Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
St Vincent's Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
ORCID: 0000-0002-9282-8619

Michelle Ananda-Rajah (M)

Department of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
General Medical Unit, Alfred Health, Melbourne, Victoria, Australia.

Nicole Gilroy (N)

Centre for Infectious Diseases and Clinical Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.

Raina MacIntyre (R)

Biosecurity Program, The Kirby Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia.

Benjamin Teh (B)

National Centre for Infections in Cancer, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.
Department of Infectious Diseases, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.

Robert Weinkove (R)

Wellington Blood and Cancer Centre, Capital and Coast District Health Board, Wellington, New Zealand.
Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand.

Jennifer Curnow (J)

Department of Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Sydney Centres for Thrombosis and Haemostasis, Sydney, New South Wales, Australia.

Jeff Szer (J)

Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
ORCID: 0000-0001-6783-2301

Anoop K Enjeti (AK)

NSW Health Pathology, John Hunter Hospital, Newcastle, New South Wales, Australia.
Department of Haematology, Calvary Mater Newcastle, Newcastle, New South Wales, Australia.
School of Medicine and Public Health Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia.

David M Ross (DM)

Department of Hematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, Australia.
Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.
Precision Medicine Theme, South Australian Health and Medical Research Institute, and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.

Stephen Mulligan (S)

Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Chronic Lymphocytic Leukaemia Australian Research Consortium (CLLARC), Australia.

Judith Trotman (J)

Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Department of Haematology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
ORCID: 0000-0001-8009-4593

Michael Dickinson (M)

Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
ORCID: 0000-0002-1492-5966

Hang Quach (H)

Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.

Phillip Choi (P)

ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.
The National Platelet Research and Referral Centre (NPRC), Canberra, Australian Capital Territory, Australia.
Haematology Department, The Canberra Hospital, Canberra, Australian Capital Territory, Australia.
ORCID: 0000-0001-9340-8125

Mark N Polizzotto (MN)

Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
St Vincent's Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Constantine S Tam (CS)

Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.

P Joy Ho (PJ)

Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Department of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

Matthew Ku (M)

Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.
ORCID: 0000-0002-9289-1335

Gareth Gregory (G)

Department of Haematology, Monash Health, Melbourne, Victoria, Australia.

Shane Gangatharan (S)

Faculty of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Department of Haematology, Fiona Stanley Hospital, Perth, Western Australia, Australia.

Greg Hapgood (G)

Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
ORCID: 0000-0002-7980-8496

Tara Cochrane (T)

Department of Haematology, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
Faculty of Medicine, Griffith University, Brisbane, Queensland, Australia.

Chan Cheah (C)

Faculty of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
Department of Haematology, Pathwest Laboratory Medicine, Perth, Western Australia, Australia.

Simon Gibbs (S)

Department of Haematology, Eastern Health, Melbourne, Victoria, Australia.
Faculty of Medicine, Monash University, Melbourne, Victoria, Australia.

Andrew Wei (A)

Department of Clinical Hematology, The Alfred Hospital, Melbourne, Victoria, Australia.
Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.

Anna Johnston (A)

Department of Haematology, The Royal Hobart Hospital, Hobart, Tasmania, Australia.
Faculty of Medicine, University of Tasmania, Hobart, Tasmania, Australia.

Matthew Greenwood (M)

Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
ORCID: 0000-0002-3667-2613

H Miles Prince (HM)

Clinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Department of Haematology, Epworth Healthcare, Melbourne, Victoria, Australia.

Maya Latimer (M)

Haematology Department, The Canberra Hospital, Canberra, Australian Capital Territory, Australia.

Leanne Berkahn (L)

Department of Haematology, The Auckland City Hospital, Auckland, New Zealand.
Faculty of Medicine, University of Auckland, Auckland, New Zealand.

Joel Wight (J)

Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Faculty of Medicine, Townsville University Hospital, Townsville, Queensland, Australia.

Tasman Armytage (T)

Department of Haematology, Gosford Hospital, Gosford, New South Wales, Australia.

Nada Hamad (N)

Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
St Vincent's Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
ORCID: 0000-0001-7929-1450

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre la COVID-19 › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Hématologie › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Nouvelle-Zélande › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › COVID-19 vaccination in haematology patients:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › COVID-19 vaccination in haematology patients:...